Pine Valley Investments Ltd Liability Co Invests $24.35 Million in Molina Healthcare, Inc $MOH

Pine Valley Investments Ltd Liability Co bought a new stake in Molina Healthcare, Inc (NYSE:MOH) during the 1st quarter, HoldingsChannel reports. The fund bought 182,656 shares of the company’s stock, valued at approximately $24,348,000. Molina Healthcare comprises approximately 1.1% of Pine Valley Investments Ltd Liability Co’s holdings, making the stock its 16th biggest position.

A number of other institutional investors and hedge funds have also made changes to their positions in MOH. 7G Capital Management LLC acquired a new stake in Molina Healthcare in the fourth quarter valued at about $1,735,000. BNP Paribas Financial Markets increased its position in Molina Healthcare by 63.0% during the 4th quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock worth $76,248,000 after purchasing an additional 169,739 shares during the period. Allspring Global Investments Holdings LLC increased its position in Molina Healthcare by 27.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 38,913 shares of the company’s stock worth $6,944,000 after purchasing an additional 8,381 shares during the period. M&T Bank Corp raised its stake in shares of Molina Healthcare by 451.1% during the 4th quarter. M&T Bank Corp now owns 42,455 shares of the company’s stock worth $7,368,000 after buying an additional 34,751 shares in the last quarter. Finally, Aurora Investment Managers LLC. purchased a new position in shares of Molina Healthcare during the 1st quarter worth approximately $2,349,000. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Stock Up 0.2%

MOH opened at $196.10 on Monday. The business’s fifty day moving average is $207.67 and its two-hundred day moving average is $177.56. The company has a debt-to-equity ratio of 0.95, a quick ratio of 1.68 and a current ratio of 1.68. The company has a market cap of $10.24 billion, a price-to-earnings ratio of -1,089.40, a PEG ratio of 28.02 and a beta of 0.75. Molina Healthcare, Inc has a one year low of $121.06 and a one year high of $244.89.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, July 22nd. The company reported $1.51 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.12. Molina Healthcare had a positive return on equity of 3.73% and a negative net margin of 0.02%.The company had revenue of $10.87 billion for the quarter, compared to analyst estimates of $10.83 billion. During the same quarter in the prior year, the company earned $5.48 earnings per share. Molina Healthcare’s revenue was down 4.8% compared to the same quarter last year. Analysts anticipate that Molina Healthcare, Inc will post 5.29 EPS for the current fiscal year.

Insider Activity

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the firm’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares in the company, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. The trade was a 4.47% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.44% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. Wells Fargo & Company reduced their target price on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating for the company in a report on Tuesday, July 28th. Cantor Fitzgerald reaffirmed a “neutral” rating on shares of Molina Healthcare in a research note on Friday, July 24th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $129.00 price target on shares of Molina Healthcare in a report on Friday, April 24th. Robert W. Baird boosted their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a report on Monday, May 11th. Finally, Truist Financial lowered their target price on shares of Molina Healthcare from $250.00 to $225.00 and set a “hold” rating on the stock in a research report on Friday, July 24th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $202.44.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.